Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutations
Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Inserti…
44 viewsMay 1, 2024
vumedi.com
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Results from MARIPOSA | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
Nov 14, 2023
targetedonc.com
Dr Girard on the Efficacy of First-Line Amivantamab Plus Chemotherapy in EGFR Exon 20 Insertion NSCLC | OncLive
Dr Girard on the Efficacy of First-Line Amivantamab Plus Chemothe…
Oct 21, 2023
onclive.com
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Treatment in EGFR Exon 20 Insertion–Mutated Advanced NSCLC: Primary Results From PAPILLON, a Randomized Phase 3 Global Study | OncLive
13:44
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Tre…
6 days ago
onclive.com
Amivantamab + Lazertinib Versus Osimertinib as 1L Treatment in EGFR-Mutated Advanced NSCLC: Primary Results From MARIPOSA | OncLive
13:00
Amivantamab + Lazertinib Versus Osimertinib as 1L Treatment in EG…
1 week ago
onclive.com
Dr Hassan on the CHRYSALIS trial of Amivantamab in EGFR Exon 20–Mutated NSCLC | OncLive
Dr Hassan on the CHRYSALIS trial of Amivantamab in EGFR Exon 20…
2 weeks ago
onclive.com
Amivantamab Plus Chemotherapy (With or Without Lazertinib) vs Chemotherapy in EGFR-mutated, Advanced NSCLC After Progression on Osimertinib
21:25
Amivantamab Plus Chemotherapy (With or Without Lazertinib) vs Ch…
Oct 31, 2023
onclive.com
ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantam…
140 viewsJun 11, 2024
vumedi.com
2:07
Dr Sabari on the FDA Approval of Frontline Amivantamab Plus Che…
Mar 29, 2024
onclive.com
1:34
Dr Sabari on the FDA Approval of Amivantamab/Lazertinib in EGFR …
Sep 4, 2024
onclive.com
Novel Mechanisms Set FDA-Approved Amivantamab-Lazertini…
Aug 30, 2024
ajmc.com
Dr. Marmarelis on the Efficacy of Lazertinib/Amivantamab Plus Che…
Aug 8, 2022
onclive.com
ASCO® 2024 Insights: "CHRYSALIS-2 Trial - Amivantamab + Lazertini…
84 viewsJun 14, 2024
vumedi.com
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: …
275 viewsJul 19, 2021
vumedi.com
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
Dr Leighl on Amivantamab in Advanced NSCLC With MET Exon …
Sep 12, 2023
onclive.com
MARIPOSA-2: Amivantamab and Chemotherapy in EGFR-Mutant N…
Dec 27, 2023
onclive.com
PAPILLON Study - Amivantamab Chemo vs. Chemo as 1L Treatmen…
854 viewsNov 17, 2023
vumedi.com
8:58
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both i…
Jun 25, 2024
onclive.com
Dr Joshua Sabari Discusses Amivantamab’s First-Line Approv…
Mar 4, 2024
ajmc.com
WCLC 2024 Insights: MARIPOSA - Amivantamab Lazertinib vs. Osim…
449 viewsSep 20, 2024
vumedi.com
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mu…
Jun 19, 2024
onclive.com
3:48
Amivantamab Accolades Add Up for NSCLC | AJMC
Sep 27, 2024
ajmc.com
1:36
CHRYSALIS: Amivantamab for EGFR exon 20 insertion mutant N…
2.5K viewsFeb 26, 2021
YouTubeVJOncology
ESMO 2024 Insights: Acquired Resistance to 1L Amivantamab + …
201 viewsOct 1, 2024
vumedi.com
5:18
Expert video report on amivantamab in combination therapy for 1L trea…
2.4K viewsOct 30, 2023
YouTubeEuropean Society for Medical Oncology (ESMO)
16:45
Amivantamab in combination with lazertinib for osimertinib-relapsed…
1.7K viewsAug 4, 2021
YouTubeecancer
4:17
Highlights on amivantamab after progression on osimertinib in EGF…
1.9K viewsOct 23, 2023
YouTubeEuropean Society for Medical Oncology (ESMO)
4:27
Amivantamab shows robust efficacy in post-platinum therapy patients …
486 viewsMay 16, 2023
YouTubeecancer
20:46
MARIPOSA - Combination of Amivantamab & Lazertinib for Co…
3.4K views8 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discus…
See more videos
Static thumbnail place holder